These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15494355)

  • 1. Comparison between somatostatin analogues and ACE inhibitor in the NOD mouse model of diabetic kidney disease.
    Segev Y; Eshet R; Rivkis I; Hayat C; Kachko L; Phillip M; Landau D
    Nephrol Dial Transplant; 2004 Dec; 19(12):3021-8. PubMed ID: 15494355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse.
    Landau D; Segev Y; Afargan M; Silbergeld A; Katchko L; Podshyvalov A; Phillip M
    Kidney Int; 2001 Aug; 60(2):505-12. PubMed ID: 11473633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products.
    Zheng F; He C; Cai W; Hattori M; Steffes M; Vlassara H
    Diabetes Metab Res Rev; 2002; 18(3):224-37. PubMed ID: 12112941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model.
    Buléon M; Allard J; Jaafar A; Praddaude F; Dickson Z; Ranera MT; Pecher C; Girolami JP; Tack I
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1249-56. PubMed ID: 18367657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
    Moriyama T; Oka K; Ueda H; Imai E
    Clin Exp Nephrol; 2004 Sep; 8(3):230-6. PubMed ID: 15480900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of growth hormone in the pathogenesis of diabetic kidney disease.
    Flyvbjerg A
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():525-9. PubMed ID: 16444187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and renal growth hormone-IGF1 axis involvement in a mouse model of type 2 diabetes.
    Segev Y; Eshet R; Yakir O; Haim N; Phillip M; Landau D
    Diabetologia; 2007 Jun; 50(6):1327-34. PubMed ID: 17443310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of octreotide on renal and glomerular growth in early experimental diabetes in mice.
    Grønbaek H; Nielsen B; Schrijvers B; Vogel I; Rasch R; Flyvbjerg A
    J Endocrinol; 2002 Mar; 172(3):637-43. PubMed ID: 11874712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y; Yokote K; Sonezaki K; Fujimoto M; Kobayashi K; Kawamura H; Tokuyama T; Takemoto M; Ueda S; Kuwaki T; Mori S; Wahren J; Saito Y
    Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice.
    Segev Y; Landau D; Rasch R; Flyvbjerg A; Phillip M
    J Am Soc Nephrol; 1999 Nov; 10(11):2374-81. PubMed ID: 10541297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.